# OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.

> **NCT04493632** · — · RECRUITING · sponsor: **OncoSil Medical Limited** · enrollment: 500 (estimated)

## Conditions studied

- Pancreatic Neoplasm
- Digestive System Neoplasm
- Neoplasms by Site
- Neoplasms
- Endocrine Gland Neoplasm
- Digestive System Disease
- Pancreatic Diseases
- Endocrine System Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04493632
- **Lead sponsor:** OncoSil Medical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-12
- **Primary completion:** 2025-11-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04493632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04493632, "OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04493632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*